Market statusData NSENot investment advice
EPIGRAL

EPIGRAL Latest Share Price (EPIGRAL)

NSE: EPIGRALBSE 543332ChemicalsSpecialty Chemicalswww.epigral.com
TechnicalsTV Chart
1,131.10
18.70−1.63%
Overall Score57/100
Day range1,117
₹1,131.10
1,156
52-week807
₹1,131.10
1,809
Above low+40.2%
Below high37.5%
Range position32%
Open1,155.90
Prev Close1,149.80
Bid1,131.04100
Ask1,131.16100

TODAY IN ONE LINE

EPIGRAL fell 1.6% on average volume, lagging Nifty's -0.3% move.

With a market cap of ₹4,887.7 Cr., it trades at a P/E of 18.03. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.

Volume22.4K71%vs 20D avg
Price Band20
Lower Band919.9
Upper Band1,379.7
Tick Size0.10
Daily Volatility2.72%
Annualised Vol51.97%
Market Cap₹4,887.7 Cr.
PromoterNot applicable
Face Value₹10
Fwd P/E10.61
PEG1.19
EV/EBITDA8.45
P/S1.87
ROA7.51%
Beta1.26
Div Payout11.05%
THE STOCK SCORE
Overall Score57/100
Updated 14 Sept

How good is this company?

Overall performance across 5 key dimensions.

Each card tappable → shows formula + inputs
FLAGS & NEWS

EPIGRAL flags & news 

Key strengths, potential risks, and recent updates.

4 green flags🚩 1 red flag

Green Flags

  • Healthy Operating MarginsOPM is structurally strong at 16.4%
  • Reasonable ValuationTrading at a moderate P/E of 13.8x
  • Virtually Debt-FreeVery low Debt-to-Equity of 0.25x
  • Zero Pledge RiskNo recent active promoter pledging found

Red Flags

  • Earnings DeclineEPS (TTM) has contracted by 6.8% YoY

Latest EPIGRAL News

THE CHANGELOG

What changed recently?

Recent events, corporate actions, and announcements.

No recent changes found for this period.
🔒Prime: full history + alerts on this stock
Valuation

EPIGRAL valuation: P/E, P/B and sector benchmarks.

Twelve years of multiples investors have paid for EPIGRAL, framed against the sector median so the premium or discount is obvious at a glance.

EPIGRAL trades at a P/E of 18.03× and P/B of 2.20×.

Key MetricsMarket + reported · 11 Sept 2026Consolidated

Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.

Valuation

Valuation

Market Cap
₹4,887.7 Cr.
P/E Ratio
18.03
P/B Ratio
2.2
EPS
₹22.99
Profitability

Profitability

ROE
14.94%
ROCE
11.04%
Net Margin
13.14%
Op Margin
16.37%
Growth

Growth

EPS YoY
-6.8%
Revenue YoY
17.3%
Qtr Sales
Qtr Profit
-0.56%
Financial Health

Financial Health

Debt / Equity
0.25
Book Value
₹514.92
Div Yield
0.44%
Promoter Holding
Not applicable
Technicals

EPIGRAL technical analysis: indicators, pivots and CPR.

Latest RSI, MACD and moving-average signals plus the latest pivot and Central Pivot Range levels for EPIGRAL — derived from the latest tape, not yesterday's close.

EPIGRAL last traded at ₹1,131.1 with an intraday range of ₹1,117–₹1,155.9 — latest indicator, pivot and CPR signals below.

Last updated: 15 September 2026, 4:08 pm IST

Pivot points

Standard pivot — most widely referenced.

Pivot levels · Classic

Last: ₹1131.10
LevelPrice (₹)Distance% Δ
R41230.13+99.03+8.76%
R31191.23+60.13+5.32%
R21173.57+42.47+3.75%
R11152.33+21.23+1.88%
PIVOT1134.673.570.32%
CURRENT1131.10
S11113.43-17.67-1.56%
S21095.77-35.33-3.12%
S31074.53-56.57-5.00%
S41035.63-95.47-8.44%
CPR Levels
Support
Resistance
S4
S3
S2
S1
| CPR |
BC: 1132.88P: 1134.67TC: 1136.45
R1
R2
R3
R4
indicator
LTP: 1131.10
PDH: 1175.00
PDL: 1140.00
● Market Sentiment

EPIGRAL is trading Below CPR, indicating Bearishness

● CPR Width

CPR is Average

● Opening Range

Day's range: 1123.31155.9

● Price Position

Trading Below opening range, showing Bearishness

Financials

EPIGRAL financials: P&L, balance sheet, cash flow, ratios.

Reported annual and quarterly results for EPIGRAL — consolidated or standalone — with margins, YoY growth and key ratios inline.

EPIGRAL reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹4,887.7 Cr. and reported EPS of ₹22.99.

iTap any row for a plain-English meaningChange vs a year ago — green means the move is healthy for that line, red means it isn’tDerivedCalculated by us, not reported directly
Mobile view
Latest vs previous year
MetricMar 2025Mar 2026
Revenue from Operations2,550
2,527
0.9%
Sales Growth YoY %Derived32.19%
-0.90%
Other Income15
15
1.5%
Total Income2,565
2,542
0.9%
1,353
1,430
5.6%
Gross ProfitDerived1,197
1,097
8.3%
Gross Margin %Derived46.92%
43.43%
486
530
9.2%
EBITDA (Operating Profit)Derived711
567
20.2%
OPM %Derived27.87%
22.44%
186
240
29.3%
Profit Before Tax (PBT)540
342
36.7%
183
9
95.2%
Effective Tax %Derived33.96%
2.57%
Total Profit for Period358
332
7.2%
Net Profit (Owner's PAT)Derived358
332
7.2%
Net Profit Margin %Derived14.03%
13.14%
PAT Growth YoY %Derived82.67%
-7.19%
Earnings Per Share (EPS ₹)82.91
76.95
7.2%
Diluted Shares Outstanding (Cr)4
4
0.0%
Share of Profit from Associates/JVs1
-1
205.1%
Other Comprehensive Income (Net of Tax)-0
0
107.1%
Total Expenses (incl. D&A & Interest)2,025
2,200
8.6%
Material Cost % of RevenueDerived51.86%
58.99%
Employee Cost % of RevenueDerived4.49%
5.13%
Other Cost % of RevenueDerived14.57%
15.86%
Interest Coverage (x)Derived10.85x
5.54x
Sales CAGR · 3Y
+4.9%
PAT CAGR · 3Y
-2.1%
all values in ₹ Cr unless marked % / x / ₹ · fiscal-period end shown · reported figures via Stockezee financials API · annual results may be audited; quarterly results may be unaudited or limited-review
Segment Analysis

EPIGRAL segment analysis : revenue and profit mix.

Disclosed business segments at EPIGRAL with their share of revenue and profit, switchable between consolidated and standalone reporting.

EPIGRAL discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.

Segment-wise Financial Analysis

Thesis

The Bull, Bear, and Flip case for EPIGRAL.

Our AI distills the core fundamental drivers supporting EPIGRAL, the risks that threaten it, and the quantitative conditions that could weaken the thesis.

EPIGRAL's investment case rests on 10 positive markers and 10 flagged concerns drawn from the latest reported filings.

bull case

What you're getting.

  • Operating margin 16.02% TTM outpaces specialty chemicals peers, demonstrating superior cost control.

  • P/E 13.76x trades significantly below sector median, offering compelling valuation for value investors.

  • ROCE 14.50% and ROE 14.99% reflect efficient capital deployment in manufacturing operations.

  • D/E ratio 0.0025 indicates minimal leverage; strong operating cash flow ensures robust debt service.

  • TTM revenue growth 17.30% YoY sustains robust demand across CPVC, chemicals, and energy verticals.

bear case

Key Risks.

  • Latest quarterly EPS declined 6.80% YoY despite revenue growth, signaling earnings pressure.

  • Quarterly sales declined 6.86% YoY, indicating near-term demand softness in key markets.

  • Dividend yield 0.41% remains modest, limiting income appeal for yield-focused investors.

  • Stock trading near 52-week low ₹807, exposing investors to significant price volatility.

  • Total debt ₹562.99 Cr reflects elevated leverage for specialty chemicals manufacturing sector.

flip conditions

Flip Conditions.

  • Valuation risk. a P/E above 23 would leave less room for earnings disappointment.

  • Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.

  • Watch interest coverage if debt-to-equity climbs above 1.00. Balance sheet risk re-prices growth multiples fast.

  • Return-quality risk. ROE below 10% would indicate weaker capital compounding.

Shareholding

EPIGRAL shareholding pattern: promoters, FII, DII and public.

Quarter-on-quarter ownership shifts in EPIGRAL — who is buying, who is exiting, and which institutions hold the largest positions.

Shareholding Pattern

AnnualJun 2026

Promoters68.83%
Govt0.02%
Public24.55%0.15%
FII1.03%0.51%
DII5.56%0.66%

Ownership Distribution

Promoters
68.83%
Government Holdings
0.02%
Retail & Public
24.55%
Foreign Institutions
1.03%
Domestic Institutions
5.56%

Category Trends

Foreign Institutions Breakdown
Total Holding: 1.03%
Net Change: -0.51%
Category Total1.03%
Total Holding1.03%
Net Change-0.51%
Aggregate Data
Institution Name
Trend (Last 6)
Holding %
QoQ Change
YoY ChangePeriod

Foreign Institutions: 1.03%

Individual institutional breakdown is not disclosed by the company, but aggregate holding data is shown above.

💡 This category has 1.03% total holding without detailed institution-wise disclosure
Peers

EPIGRAL peer comparison — same-sector benchmarks.

Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — EPIGRAL is highlighted for quick read-across.

Quick Compare

Largest by Market Cap
PIDILITE INDUSTRIES
₹1.60 Lakh Cr
Best Profit Growth
DIAMINES & CHEMICALS
364.47 %
Highest Dividend Yield
BHANSALI ENG. POLYMERS LT
3.11 %

Peer Comparison

Company Name
09 · Chart Patterns

EPIGRAL chart patterns: breakouts, tops and bottoms.

Auto-detected classical chart patterns for EPIGRAL — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.

Delivery Conviction

EPIGRAL delivery volume — last 20 sessions of conviction.

Daily traded volume and delivery percentage for EPIGRAL over 20 sessions — the gap between intraday flipping and genuine accumulation.

Latest session delivery in EPIGRAL stood at 60.4% of traded volume, against a 20-day average of 51.0%.

Avg Delivery (20D)51%+9.4 ppt latest vs avg
Highest Delivery70.2%on 18 Aug
Avg Volume (20D)77.5 K20-day run-rate
Conviction Trend↓ Weakening+9.4 ppt latest read
Volume & Delivery · last 20 sessions
Exchange Filings & Investor Updates

EPIGRAL announcements: results, concalls, ratings, M&A.

Filings EPIGRAL sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.

EPIGRAL files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 149 documents below.

  1. 31 Aug 2026Analysts/Institutional Investor Meet/Con. Call UpdatesView PDF

    Analysts/Institutional Investor Meet/Con. Call Updates

    Epigral Limited has informed the Exchange about Investor / Analyst Plant Visit on Thursday, 03.09.2026

  2. 18 Aug 2026Analysts/Institutional Investor Meet/Con. Call UpdatesView PDF

    Analysts/Institutional Investor Meet/Con. Call Updates

    Epigral Limited has informed the Exchange about One-on-One Meeting with Investor / Analyst on thursday, 20.08.2026

  3. 07 Aug 2026Analysts/Institutional Investor Meet/Con. Call UpdatesView PDF

    Analysts/Institutional Investor Meet/Con. Call Updates

    Epigral Limited has informed the Exchange about participation in EMKAY Confluence 2026 on 12th August, 2026

  4. 30 Jul 2026Analysts/Institutional Investor Meet/Con. Call UpdatesView PDF

    Analysts/Institutional Investor Meet/Con. Call Updates

    Epigral Limited has informed the Exchange about One-on-One Meeting with Investor / Analyst on Monday, 3rd August, 2026.

  5. 30 Jul 2026Analysts/Institutional Investor Meet/Con. Call UpdatesView PDF

    Analysts/Institutional Investor Meet/Con. Call Updates

    Epigral Limited has informed the Exchange about Transcript

Corporate Actions

EPIGRAL dividend history, splits and bonus issues.

Every dividend, stock split and bonus issue EPIGRAL has declared, sequenced by announce and record date.

EPIGRAL corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.

About the Company

About EPIGRAL: business, sector, key facts.

What EPIGRAL does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.

EPIGRAL operates in the Specialty Chemicals industry under the Chemicals sector, listed as NSE: EPIGRAL, BSE: 543332.

EPIGRAL
Chemicals

EPIGRAL

NSE · EPIGRAL·BSE · 543332·www.epigral.com

Epigral Limited is a prominent Indian manufacturer and seller of chlor-alkali and related chemical derivatives, operating both domestically and internationally. Their extensive product portfolio caters to a diverse range of industries, showcasing their broad reach and diverse applications within the chemical sector. The company's history, starting as Meghmani Finechem Limited before a name change in August 2023, highlights its growth and evolution in the market.

A core component of Epigral's business is the production and sale of chlorinated polyvinyl chloride (CPVC) resins and compounds. These materials find significant application in the manufacturing of CPVC pipes and fittings, demonstrating a key vertical integration within their operations. Beyond CPVC, Epigral also produces and supplies a wide array of other chemical products, including epichlorohydrin, various chloromethanes, hydrogen peroxide, caustic soda, potash, chlorine, and hydrogen. These products are further processed into other value-added chemicals like chlorotoluene, highlighting a commitment to comprehensive chemical manufacturing.

The breadth of industries served by Epigral underscores the versatility and demand for their chemical products. Their customer base spans sectors such as construction (using CPVC pipes), paints and coatings, electronics, water treatment, agrochemicals, pharmaceuticals, refineries, soap and detergent manufacturing, and various others, including the production of fluoropolymers, paper and pulp, textiles, alumina, polyurethane foam, lithium, and even PTFE pipes. This wide reach indicates Epigral’s strategic positioning across many crucial industrial sectors.

Epigral’s operations are not limited to chemical production; they also feature a significant energy component. The company operates a captive power plant (CPP) to support its manufacturing processes, ensuring a reliable and cost-effective energy supply. Furthermore, they have invested in renewable energy sources by operating a wind-solar hybrid power plant, demonstrating a commitment to sustainable practices and energy independence. This integrated approach to energy production underlines their commitment to operational efficiency and environmental responsibility.

company facts
Employees1,135
SectorChemicals
HeadquartersAhmedabad, India
Market Cap₹4,887.7 Cr.
Listed OnNSE
leadership22 on record
Amritlal Rathod
Head of H2O2 Process
Jitesh Vaghani
Process Head of Technology
Mr. Ankit Patel
Non-Executive Non-Independent Director
Mr. Darshan Patel
Non-Executive Non-Independent Director
Mr. Gaurang Ghanshyam Trivedi
Company Secretary & Compliance Officer
Mr. Gaurang Trivedi
Compliance Officer, Company Secretary
Mr. Kanubhai Patel
Non-Executive Independent Director
Mr. Karana Patel
Non-Executive Non-Independent Director
Mr. Kaushal Ashisbhai Soparkar
CEO & Executive Director
Mr. Kaushal Soparkar
Executive Director
Mr. Maulik Jayantibhai Patel
Chairman & MD
Mr. Maulik Patel
Chairman of the Board, Managing Director
§ ∞ · Plainly Answered

Questions investors ask about EPIGRAL (EPIGRAL).

Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.

01What is the current share price of EPIGRAL (EPIGRAL)?

The current share price of EPIGRAL (EPIGRAL) is ₹1,131.10. Today, the stock has declined by ₹18.70 (1.63%), trading in a range of ₹1,117.00 to ₹1,155.90. The stock opened at ₹1,155.90 with a trading volume of 22,425 shares.

02Is EPIGRAL stock a good investment for long-term?

EPIGRAL can be considered for long-term investment based on several factors. The company has a market capitalization of ₹4,887.7 Cr., P/E ratio of 18.03, ROE of 14.94%, and ROCE of 11.04%. The dividend yield stands at 0.44%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.

03What is the 52-week high and low price of EPIGRAL stock?

The 52-week high price of EPIGRAL (EPIGRAL) is ₹1,808.80, while the 52-week low is ₹807.00. Currently trading at ₹1,131.10, the stock is 40.16% above its 52-week low and 37.47% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.

04Should I buy EPIGRAL stock at the current price?

Whether to buy EPIGRAL stock at ₹1,131.10 depends on multiple factors. The stock is currently trading with a P/E ratio of 18.03 and P/B ratio of 2.2. Today's performance shows a loss of 1.63%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.

05What is the dividend yield of EPIGRAL and when is the next dividend?

EPIGRAL offers a dividend yield of 0.44%, which means for every ₹100 invested at the current price of ₹1,131.10, you can expect to receive approximately ₹0.44 annually as dividends. The face value of the stock is ₹10.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.

06What are the key financial ratios and metrics of EPIGRAL?

EPIGRAL's key financial metrics include: P/E Ratio: 18.03, P/B Ratio: 2.2, ROE: 14.94%, ROCE: 11.04%, Dividend Yield: 0.44%, EPS: ₹22.99, Book Value: ₹514.92, and Debt-to-Equity: 0.25. The company's market cap stands at ₹4,887.7 Cr.. These metrics help evaluate the company's valuation, profitability, and financial health.

07How is EPIGRAL stock performing today in the market?

EPIGRAL stock opened at ₹1,155.90 and is currently trading at ₹1,131.10, showing a decline of ₹18.70 (1.63%). The intraday high is ₹1,155.90 and low is ₹1,117.00. The trading volume stands at 22,425 shares, indicating moderate market participation today.

08What is the P/E ratio of EPIGRAL and what does it indicate?

EPIGRAL has a Price-to-Earnings (P/E) ratio of 18.03, which means investors are willing to pay 18.03 for every ₹1 of earnings. With an EPS of ₹22.99, this P/E ratio indicates moderate valuation in line with market standards. Compare this with industry peers and historical P/E ratios for better context.

Disclaimer

The data, ratios and commentary about EPIGRAL (EPIGRAL) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.